Patterns of progression under antiPD1/PDL1 in advanced NSCLC patients allow discriminating pseudo-progression from real progression

Caramella, C; Tazdait, M; Mezquita, L; Lahmar, J; Ferrara, R; Marabelle, A; Balleyguier, C; Planchard, D; Gazzah, A; Soria, JC; Besse, B

ANNALS OF ONCOLOGY, 2017; 28 ( ):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索